Summary
Has President's Emergency Plan for AIDS Relief's (PEPFAR) funding been effective in reducing the rate of HIV new infections and AIDS-related deaths among women and children? While previous studies have found HIV/AIDS aid to be ineffective and PEPFAR funding to produce negative externalities, there is lack of empirical examination of the impact of PEPFAR on women and children despite the emphasis on prevention of mother-to-child transmission of HIV during the Bush and Obama administrations. Using descriptive analysis and difference-in-differences (DID) regression, this study finds that PEPFAR's funding has reduced the HIV new infections and AIDS-related death rates of women and children for both focus countries and recipient countries, which are those that were added in a second phase. These findings show that PEPFAR's strategy for women and children has been effective and that it should be continued. However, while PEPFAR has contributed to the fight against HIV/AIDS, the effects of its work have been underestimated. PEPFAR has implemented comprehensive strategies for improving women's health through HIV prevention and through care and treatment, including the expansion of provision of antiretroviral treatment (ART) for mothers and their children. Despite the work of PEPFAR toward reducing the rates of HIV infection and AIDS-related death of women and children, the literature in this area lacks empirical analysis as to how effective PEPFAR's efforts have been.
Focusing on African countries, this study finds that PEPFAR's support has effectively reduced incidence of new HIV infection and AIDS-related death among women and children in recipient countries during the first and second phases (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . This study also finds that PEPFAR funding has had significant impact in reducing new HIV infection and AIDS-related death rates among these populations in the recipient countries that were added during the second phase.
In the following section, I discuss the relevant literature and how the PEPFAR programs for women and children were implemented. My research design, methods, and results are then presented. The last section offers a brief review of the main findings and concludes with policy recommendations.
| LITERATURE REVIEW
As the largest health initiative for a single disease in the world, PEPFAR has emphasized the reduction of new infections in children and the prevention of mother-to-child transmission. Among the research that investigates the effects on children and women of foreign aid for HIV, one group of scholars finds that HIV/AIDS related to Official Development Assistance (ODA) 6 or PEPFAR 7, 8 have been ineffective in responding HIV/AIDS for these populations, while another group of scholars finds that it has been effective in reducing rates of both new infection and AIDSrelated death among children and women. 9, 10 Despite the emphasis on prevention of mother-to-child-transmission (PMTCT), there has been a lack of empirical examination of this issue, and most studies are limited to analyzing case studies rather than conducting large-N empirical analysis, examining the effects of PMTCT using projected numbers or focusing on short-time analysis. 8, 9 Dutta et al investigate whether there were trade-offs between investing in the health system and scaling up PMTCT programs under PEPFAR in Kenya from 2005 to 2010. 9 They find that while the average unit expenditure for ARV of HIV-positive mothers decreased 52%, thus became much more affordable, expenditure for health system strengthening increased. According to them, PEPFAR was able to provide PMTCT at a more reasonable price while investing in the Kenyan health system at the same time. Using the spectrum modules in 16 African countries, Heaton et al compare the reality of PEPFAR-supported interventions with a speculative scenario without PEPFAR and find that PEPFAR provided ART for PMTCT to about four million pregnant women between 2004 and 2013. 10 One limitation of this study is that it overestimates PEPFAR's contribution by using the predicted number of ART provisions.
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On the other hand, Ginsburg et al analyze PMTCT programs in 18 resource-limited countries, most of which are PEPFAR focus countries, between 2005 and 2006, and find that the majority of pregnant women who received highly active antiretroviral therapy (HAART) did not take it at PMTCT sites, and so they conclude that PMTCT programs are not fully integrated with maternal-child health (MCH) systems. 11 Barker and Mate examine the relationship between clinic attendance for maternal care and the provision of antiretroviral drugs in 10 African countries and argue that poor accessibility to these health systems may have led to a 67% increase of transmission rates; thus, an expanded and effective health system under PEPFAR support is necessary for more accessible care and consequent elimination of mother-to-child transmission. However, while Barker and Mate point out that their model is limited in terms of accurate prediction, 7 it is also unclear how general maternal care-including immunization for diphtheria, tetanus, and polio-is related to mother-to-child HIV transmission, and there is lack of evidence as to whether expanded provision of antiretroviral drugs affects this transmission rate.
Ezegbe and Stephenson examine the effects of PEPFAR funding for PMTCT in Nigeria and reveal that 70% of HIV-positive pregnant women do not receive any primary prevention and that PEPFAR invests more in psychosocial counseling than in maternal and child ARV treatment, concluding that PEPFAR's work falls far short of comprehensive support for PMTCT in Nigeria. 8 Examining the impact of HIV/AIDS-related ODA on HIV/AIDS epidemics, Nunnenkamp and Ohler find that while HIV/AIDS-related ODA does not reduce new infections of HIV, US funding has decreased AIDS-related deaths. 6 One limitation of this study is that it uses the change in number of people affected by new HIV infections and AIDS-related death as dependent variables. But in place of this absolute number, the proportion of these people to total country population is necessary for accurate comparison among countries of these effects. In addition to impact on HIV/AIDS, Lee and Izama investigate some negative externalities of PEPFAR funding, focusing on neonatal mortality. They argue that the annual change rate of neonatal mortality in PEPFAR focus countries decreased more slowly than in nonfocus countries. 12 However, if we consider that focus countries have higher HIV infection and AIDS-related death rates, this slowed rate of change is not surprising. In a complex situation where diverse arguments regarding HIV/AIDS-related ODA and PEPFAR exist, this study aims to reveal the impact of PEPFAR on women and children in terms of new HIV infection and AIDS-related death rates. In terms of gender strategy, during the first phase, the Bush administration put an emphasis on Abstinence, Be faithful, Use a Condom (ABC) prevention, 14 even while PEPFAR pursued increased gender equity in HIV/AIDS activities and services. During the second phase, PEPFAR has made PMTCT a primary means of improving the health of women (see Tables 1 and 2 ). For instance, in 2009, the Obama administration identified maternal and child health (MCH) as one of its global health priorities and allocated $12 billion over 6 years for maternal and child health, family planning, and neglected tropical diseases. 15 In 2011, the US government joined with UNAIDS to initiate the Global Plan toward the Elimination of New Pediatric Infections and Keeping Mothers Alive with the main goal of reducing new pediatric infections. In 2015, the Obama administration announced that it would invest half a billion dollars through PEPFAR to reduce HIV infections among adolescent girls and young women in 10 sub-Saharan African countries in the DREAM initiative, which stands for Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe lives. 16 In keeping with its philosophy that protecting women's rights is central to improving their well-being, the Obama administration implemented policies to improve women and girls`economic and social conditions both domestically and internationally. It believed that investing in women and girls leads to more prosperous societies and that school attendance delays early marriage and childbearing, thus also reducing fertility rates and the incidence of HIV/AIDS infection. 17 Adolescent girls are at particularly high risk for HIV infections due to their economic vulnerability, as well as to early marriage and sexual abuse.
| PEPFAR'S PROGRAMS FOR WOMEN AND CHILDREN
For example, every day, more than 1000 adolescent girls and young women were infected with HIV in 2015, 17 and girls accounted for two-thirds of new HIV infections among adolescents in 2016. 18 The vast majority of adolescents who died of AIDS-related illnesses in 2013 had acquired HIV from their mothers in the first months of their lives or when their mothers were pregnant or delivering them. Therefore, interventions for HIV-positive pregnant women are efficient because they save the lives of mothers, prevent transmission to children, and reduce the number of AIDS orphans.
In 2011, Secretary of State Clinton prioritized three key evidence-based interventions for PEPFAR programs to provide more effective HIV prevention-PMTCT, voluntary medical male circumcision (VMMC), and expansion of treatment-all of which aimed to reduce the number of HIV infections and AIDS-related deaths in women and children. 19 Additionally, PEPFAR recognized that efficient programs require the expansion of family planning and antenatal care (ANC) as well as the integration of maternal and child health services in "one-stop-shop" services. And improved monitoring of PMTCT/MCH services, such as sufficient tracking of HIV-positive women and children, is required for effective prevention of mother-to-child infection.
Voluntary medical male circumcision (VMMC) is one key strategy that PEPFAR implements because it decreases male-to-female sexual transmission of HIV by 60%, 20 and it also reduces the risk of transmission to children. In its capacity to reduce overall prevalence rates, VMMC is considered a "highly effective and cost-savings" intervention, 19 and PEPFAR began to provide funding for VMMC in 2007. 21 Moreover, PEPFAR has also expanded infant, pediatric, and adolescent treatment and has plans to provide lifelong ART for pregnant and breastfeeding women living with HIV. countries because they have continuously received PEPFAR's funding since the first phase. The DID estimation is based on a group comparison between countries that received aid to those that received none at all. Thus, to reveal the effects of PEPFAR's funding on women and children's new infection and AIDS-related mortality rates, I compared the countries that were added in the second phase with those countries that had not received any aid at all.
For these analyses, I use four dependent variables-the HIV new infection rates for women and children and the AIDS-related deaths rates for women and children-by consulting data from UNAIDS. The main independent variable is the interaction term between a dummy for whether the country receives PEPFAR's funding in the specific phase and a dummy for the period.
Based on previous studies of HIV/AIDS, this study includes various control variables that are expected to influence HIV new infection rates and AIDS-related death rates for either women or children.
| GDP growth rate
The economic level of a country affects new HIV infection and AIDS-related deaths rates. 25 While some studies use GDP per capita as a control variable in examining HIV epidemic, others argue that "GDP per capita is not necessarily the most appropriate way to measure the economic impact of the epidemic." Rather, actual growth in income can be a better indicator. 26 When I use the GDP capita as a control variable, it highly correlates with the variable of per capita public health spending of 0.9. The variable inflation factor (VIFs) of these two variables are over 8, which raises the multicollinearity issue; thus, this study uses GDP growth rate to control impact of economy.
| Literacy
Populations need to be literate to understand how to prevent HIV and to access treatment. 27 Because of the limitations of literacy rate data, this study uses percent of children enrolled in primary school.
| Democracy
Type of political system is important in terms of responding to an epidemic or limiting its spread. 28, 29 This study controls for political system by using Polity IV. 30 
| Urbanization
While some scholars argue that people living in rural areas tend to have difficulty accessing health services, 12 the sheer density of urban populations can also hinder access. In addition, the increased opportunity for sexual interactions among individuals in these denser populations increases the possibility of HIV infection. 25 I use percentage of urban population to control for this impact.
| Public health spending
Not only external resources such as PEPFAR but also domestic resources may affect the fight against HIV/AIDS. Per capita public health spending is calculated from the original data of health spending as percentage of GDP and is logged due to the large gaps in this spending among countries.
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| Refugees
Because previous literature considers refugees to be one possible pathway in the spread of HIV, 25 this study controls this impact. However, this study notes that the HIV transmission rates of refugees depend on their living conditions. 31 This study uses number of refugee asylums weighted by population as a control.
| Civil war
While Iqbal and Zorn find that both civil and international wars significantly increase HIV prevalence, 25 All data come from World Bank indicators, except for civil war, democracy, and HIV rates.
| HIV rates
The HIV prevalence rates in a country may be a determinant factor of the prevalence of women and children and of AIDS-related death rates, as well. This study uses UNAIDS data.
To diagnose whether each model has a multicollinearity problem, I conduct VIF tests for all models. As a result, none of the VIF values is higher than 5.11; thus, there is no significant problem in terms of muliticollinearity. I use DID regressions to examine the effects of PFEPAR on new HIV infection and AIDS-related death rates of women and children. The DID estimation is most appropriate when one of the groups is exposed to a treatment (PEPFAR's funding) after a certain policy has been implemented, but the second group is not exposed before and after this implementation. The DID estimation is composed of before-after comparisons and with-without comparisons. 6 With-without comparisons evaluate the difference in HIV indicators between PEPFAR-recipient countries and nonrecipient countries. Before-after comparisons also reveal the differences in these indicators before and after the treatment.
If focus countries are not randomly designated, inherent differences can exist between focus and nonfocus countries that influence the differences in women and children's new HIV infection and AIDS-related death rates in this population. DID is able to remove these inherent time-invariant differences, eliminating the selection bias issue by controlling unobservable heterogeneity in the comparison of treatment and control groups. The DID model is the following:
where y ist refers to women and children's new HIV infection and AIDS-related death rates in the time t in country i.
Subscript s indexes mean whether the country was a PEPFAR-recipient country or not, γ s is a dummy variable indicating whether the country was a PEPFAR-recipient country, and λ t is a year dummy variable indicating whether the country was a PEPFAR-recipient country in a given year, X refers to other control variables that affect the dependent variable, and ε is the error term. I st is an interaction term between γ s and λ t , that shows whether PEPFAR has reduced women and children's new HIV infection and AIDS-related death rates.
Because most DID research uses panel data, there is concern about serial correlation, which can lead to smaller than actual standard errors and so cause overestimation of t-statistics and significance level. 32 Thus, Bertrand et al suggest two ways to detect the issue: using the cluster-robust standard error and block bootstrap. Following their suggestion, this study estimates the models with the cluster-robust standard error and, for a robust check, also uses the block bootstrap method. Tables 9 and 10 show the results of DID analyses in examining the impact of PEPFAR in the first phase in the focus countries. In Table 9 , the interaction term, first phase × treatment, has significant effects in models 1, 2, and 4. In terms of substantive effects, PEPFAR decreased women's rate of new infection by 43% and 56% in models 1 and 2, respectively, and reduced children's rate by 36%. Thus, PEPFAR was effective in reducing new infections for both children and women in the first phase (2004-2009). But in Table 10 , the interaction term (first phase × treatment) only has significant impact in models 7 and 8, which means that PEPFAR was effective in reducing children's AIDS-related death rate but not that of women. Substantively, PEPFAR reduced children's death rates by 26% and 21% in models 7 and 8, respectively.
I tested PEPFAR's effect on focus countries for a longer time period that includes both the first and second phases. In Table 11 , the interaction term, first and second phase × treatment, has significant effects in models 9, 10, 11, and 12, which means that PEPFAR was effective in reducing new infections both for women and for children during this longer time period (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . In terms of substantive effects, PEPFAR reduced women's new infection rate by 98% in both models 9 and 10. PEPFAR also led to the reduction of children's new infection rate by 83% and 77%
in models 11 and 12, respectively. Unlike the results of the first phase test, in which only those for children are significant, the interaction term, first and second phase × treatment, is significant in models 14, 15, and 16 in Table 12 , which shows that PEPFAR has been effective in reducing both women's and children's AIDS-related death rates in a longer term. Substantively, PEPFAR reduced women's death rate by 45% in model 14. It also decreased children's death rate by 43% and 52% in models 15 and 16, respectively. Tables 13 and 14 show the results of PEPFAR's effects on women and children in recipient countries that were only added in the second phase. In Table 13 , the interaction term, second phase × treatment, has significant effects in Numbers in parenthesis are cluster-robust standard error. ***P < 0.01. **P < 0.05. *P < 0.1. Numbers in parenthesis are bootstrap standard error. ***P < 0.01. **P < 0.05.
*P < 0.1.
KIM e913 models 17, 19, and 20, which means that PEPFAR has reduced new infection rates of the women and children in these countries. In terms of substantive effects, PEPFAR decreased women's new infection rate by 61% in model 17 and decreased children's new infection rate by 84% and 147% in models 19 and 20, respectively, which is a much larger impact than in the focus countries during the first phase. In Table 14 , the interaction term, second phase × treatment, has significant effects in all models, with, for example, a P < 0.05 significance level in models 21, 22, 23, and 24.
Substantively, PEPFAR led a reduction in women's AIDS-related death rate by 135% and 95% in models 21 and 22, respectively. PEPFAR has also been effective in decreasing children's AIDS-related death rate by 69% and 65% in models 23 and 24, respectively.
In terms of control variables, a country's HIV rates are significantly related to the new infection and AIDS-related rates of both women and children. Even though previous literature does not provide clear evidence of refugees causing the spread of HIV, a higher rate of refugees is more likely to increase the new HIV infection rate of children and AIDS-related death rates of both women and children (models 10, 14, 18, 22, 24) . As a government provides greater per capita health spending, it is more likely to reduce the number of women's and children's AIDS-related deaths, as well as that of children's new infections (models 8, 10, 14, 18, 22, 24) . The insignificant impact of per capita health spending on women's new infections may be attributed to the lack of investment of African governments in women HIV prevention, for which they tend to rely on external resources like PEPFAR. Even though it was expected that greater literacy would decrease the new infection and AIDS-related death rates of children, it slightly increases the death rate in models 6 and 14. This may be related to the argument that countries with higher economic levels are more likely to have higher HIV rates, 33 and the correlation between greater wealth and greater education.
In terms of civil war, while it is still controversial whether conflict affects HIV positively 34 or negatively, 25 my findings suggest that it may affect HIV rates positively in the short term (models 12, 22, 24), as Mock et al argue. 34 For a robust check, I also used the block bootstrap method to detect serial correlation by approximating standard errors. Bootstrapping randomly selects observations, one at a time, from the original data. Using these multiple pseudosamples, we can calculate standard errors to infer the distribution of the original standard errors. Cameron et al explain that bootstrapping provides asymptotic refinements and thus leads to improved inferences. 35 After conducting 1500 replications, Table 15 presents the bootstrapped standard errors of each interaction term in all models by five decimal places (ex 0.00005), the coefficients, and the significant level of each interaction term.
Bootstrapped standard errors are slightly larger than the cluster-robust standard errors, while the coefficient is almost the same, as shown in Lee and Izama's study. 12 As for P value, it becomes a little greater in the models with bootstrapped standard errors; thus in models 17, 20, and 24, there are significant level changes. The similar results of block bootstrap estimation support the previous findings with cluster-robust estimation that PEPFAR has been effective in reducing new HIV infection and AIDS-related death rates for both women and children.
| CONCLUSIONS
Throughout the Bush and Obama administrations, PEPFAR underscored the reduction of new HIV infections and AIDS-related deaths in women and children, even while little empirical research had been conducted on the impact of PEPFAR on women's and children's HIV issues. In three areas of empirical examination-of the first phase (test 1), from the first to second phases of focus countries (test 2), and the second phase of the countries that were added (test 3)-this study finds that PEPFAR has played a significant role in reducing new HIV infections and AIDS-related deaths in women and children.
While the Bush administration put more emphasis on the abstinence-only strategy in regards to HIV/AIDS, 36 the Obama administration promoted PMTCT, thus increasing the budget for prevention of mother-to-child transmission.
It may be due to this difference that PEPFAR's funding failed to significantly reduce women's AIDS-related mortality rates in first phase in this study. Or it may be that longer term support is necessary to reduce these rates, as the results of the second test suggest.
e914 KIM This study is limited in that, due to limitations in data, it uses new infection and AIDS-related death rates for women above the age of 15 rather than the indicators for pregnant or postpartum women. Thus, as more specific data become available, future research is needed that studies women by age groups. However, support of PEPFAR has been consistent since the launch of the International Mother and Child HIV Prevention Initiative in 2002, and this study reveals that this 14-year commitment has been effective, overall, in saving the lives of women and children and in reducing the number of their new infections. Although Nunnenkamp and Ohler find that HIV/AIDS-related ODA did not prevent new infections, 6 this study reveals that PEPFAR has prevented new infections in women and children. And this prevention was most pronounced in the long term and in countries that were added in the second phase.
This study finds that intervention was more effective in the countries added in the second phase, but as more specific data becomes available related to domestic supply systems for HIV/AIDS and to how PEPFAR has allocated its resources, further study should be able to reveal clearer reasons for the differences under the Bush and Obama administrations. In terms of policy-related implications, the findings of this study suggest that investment in PMTCT has been effective and should be continued.
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